Nopalera
PrivateLast Round
Series A
Mar 24, 2026
Est. Valuation
$5M
Total Funding Raised
$7.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nopalera is a personal products company that manufactures and sells a line of luxury Mexican botanicals for bath and body.
Sector
Consumer & Commerce
Verticals
D2C Brands, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nopalera Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nopalera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 24, 2026 | ||||
| SAFE | May 30, 2024 | ||||
| Accelerator | Sep 12, 2023 | ||||
| Seed | Oct 26, 2022 |
Nopalera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alamo Angels | Series A |
| Portfolia | Series A |
| The Center for Urban Entrepreneurship & Economic Development (CUEED) | Series A |
| Counterpoint Global (Morgan Stanley) | SAFE, Seed |
| Katalyst Impact Fund | SAFE, Seed |
| Morgan Stanley Inclusive Ventures Lab | Accelerator |
| Juniper Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
$4M round completed.
- Feb 3, 2026
Expanded into Mexico, Australia, and the Middle East, with new offices in Central America and the Americas.
Nopalera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nopalera's valuation, stock price, and market status.